Skip Nav Destination
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups
Postibrutinib outcomes in patients with mantle cell lymphoma
Issue Archive
Table of Contents
BLOOD FLASHBACK
INSIDE BLOOD COMMENTARIES
PLENARY PAPER
PLENARY PAPER
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study
Clinical Trials & Observations
Sally F. Barrington,Amy A. Kirkwood,Antonella Franceschetto,Michael J. Fulham,Thomas H. Roberts,Helén Almquist,Eva Brun,Karin Hjorthaug,Zaid N. Viney,Lucy C. Pike,Massimo Federico,Stefano Luminari,John Radford,Judith Trotman,Alexander Fosså,Leanne Berkahn,Daniel Molin,Francesco D’Amore,Donald A. Sinclair,Paul Smith,Michael J. O’Doherty,Lindsey Stevens,Peter W. Johnson
BLOOD SPOTLIGHT
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups
Clinical Trials & Observations
Marlise R. Luskin,Ju-Whei Lee,Hugo F. Fernandez,Omar Abdel-Wahab,John M. Bennett,Rhett P. Ketterling,Hillard M. Lazarus,Ross L. Levine,Mark R. Litzow,Elisabeth M. Paietta,Jay P. Patel,Janis Racevskis,Jacob M. Rowe,Martin S. Tallman,Zhuoxin Sun,Selina M. Luger
Postibrutinib outcomes in patients with mantle cell lymphoma
Clinical Trials & Observations
Peter Martin,Kami Maddocks,John P. Leonard,Jia Ruan,Andre Goy,Nina Wagner-Johnston,Simon Rule,Ranjana Advani,David Iberri,Tycel Phillips,Stephen Spurgeon,Eliana Kozin,Katherine Noto,Zhengming Chen,Wojciech Jurczak,Rebecca Auer,Ewa Chmielowska,Stephan Stilgenbauer,Johannes Bloehdorn,Craig Portell,Michael E. Williams,Martin Dreyling,Paul M. Barr,Selina Chen-Kiang,Maurizio DiLiberto,Richard R. Furman,Kristie A. Blum
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
Increased DNA methylation of Dnmt3b targets impairs leukemogenesis
Isabell Schulze,Christian Rohde,Marina Scheller-Wendorff,Nicole Bäumer,Annika Krause,Friederike Herbst,Pia Riemke,Katja Hebestreit,Petra Tschanter,Qiong Lin,Heinz Linhart,Lucy A. Godley,Hanno Glimm,Martin Dugas,Wolfgang Wagner,Wolfgang E. Berdel,Frank Rosenbauer,Carsten Müller-Tidow
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
LETTERS TO BLOOD
Age-sex–specific ranges of platelet count and all-cause mortality: prospective findings from the MOLI-SANI study
Marialaura Bonaccio,on behalf of the MOLI-SANI Investigators,Augusto Di Castelnuovo,on behalf of the MOLI-SANI Investigators,Simona Costanzo,on behalf of the MOLI-SANI Investigators,Amalia De Curtis,on behalf of the MOLI-SANI Investigators,Maria Benedetta Donati,on behalf of the MOLI-SANI Investigators,Chiara Cerletti,on behalf of the MOLI-SANI Investigators,Giovanni de Gaetano,on behalf of the MOLI-SANI Investigators,Licia Iacoviello,on behalf of the MOLI-SANI Investigators
BLOOD WORK
ERRATA
-
Cover Image
Cover Image
The function of myeloid-derived suppressor cells is impaired in the spleens of patients with immune thrombocytopenia. See the article by Hou et al on page 1587.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals